9 results on '"Comella-Del-Barrio P"'
Search Results
2. Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
- Author
-
Izquierdo-Garcia, José Luis, Comella-del-Barrio, Patricia, Campos-Olivas, Ramón, Villar-Hernández, Raquel, Prat-Aymerich, Cristina, De Souza-Galvão, Maria Luiza, Jiménez-Fuentes, Maria Angeles, Ruiz-Manzano, Juan, Stojanovic, Zoran, González, Adela, Serra-Vidal, Mar, García-García, Esther, Muriel-Moreno, Beatriz, Millet, Joan Pau, Molina-Pinargote, Israel, Casas, Xavier, Santiago, Javier, Sabriá, Fina, Martos, Carmen, Herzmann, Christian, Ruiz-Cabello, Jesús, and Domínguez, José
- Published
- 2020
- Full Text
- View/download PDF
3. A Model Based on the Combination of IFN-gamma, IP-10, Ferritin and 25-Hydroxyvitamin D for Discriminating Latent From Active Tuberculosis in Children
- Author
-
Comella-del-Barrio, P, Abellana, R, Villar-Hernandez, R, Coute, MDJ, Mingels, BS, Aliaga, LC, Narcisse, M, Gautier, J, Ascaso, C, Latorre, I, Dominguez, J, and Perez-Porcuna, TM
- Subjects
pediatrics ,ferritin ,enzyme-linked immunoassays ,biomarkers ,vitamin D ,Mycobacterium tuberculosis ,immune response ,cytokines - Abstract
In recent years, pediatric research on tuberculosis (TB) has focused on addressing new biomarkers with the potential to be used as immunological non-sputum-based methods for the diagnosis of TB in children. The aim of this study was to characterize a set of cytokines and a series of individual factors (ferritin, 25-hydroxyvitamin D [25(OH)D], parasite infections, and nutritional status) to assess different patterns for discriminating between active TB and latent TB infection (LTBI) in children. The levels of 13 cytokines in QuantiFERON-TB Gold In-Tube (OFT-GIT) supernatants were analyzed in 166 children: 74 with active TB, 37 with LTBI, and 55 uninfected controls. All cytokines were quantified using Luminex or ELISA. Ferritin and 25(OH)D were also evaluated using CLIA, and Toxocara canis Ig-G antibodies were detected with a commercial ELISA kit. The combination of IP-10, IFN-gamma, ferritin, and 25(OH)D achieved the best diagnostic performance to discriminate between active TB and LTBI cases in children in relation to the area under receiver operating characteristic (ROC) curve 0.955 (confidence interval 95%: 0.91-1.00), achieving optimal sensitivity and specificity for the development of a new test (93.2 and 90.0%, respectively). Children with TB showed higher ferritin levels and an inverse correlation between 25(OH)D and IFN-gamma levels. The model proposed includes a combination of biomarkers for discriminating between active TB and LTBI in children to improve the accuracy of TB diagnosis in children. This combination of biomarkers might have potential for identifying the onset of primary TB in children.
- Published
- 2019
4. Tobacco Smoking and Second-Hand Smoke Exposure Impact on Tuberculosis in Children.
- Author
-
Altet N, Latorre I, Jiménez-Fuentes MÁ, Soriano-Arandes A, Villar-Hernández R, Milà C, Rodríguez-Fernández P, Muriel-Moreno B, Comella-Del-Barrio P, Godoy P, Millet JP, de Souza-Galvão ML, Jiménez-Ruiz CA, Domínguez J, and On Behalf Of Pii Smoking Separ Working Group
- Abstract
Little is known about whether second-hand smoke (SHS) exposure affects tuberculosis (TB). Here, we investigate the association of cigarette smoke exposure with active TB and latent TB infection (LTBI) in children, analyzing Interferon-Gamma Release Assays' (IGRAs) performance and cytokine immune responses. A total of 616 children from contact-tracing studies were included and classified regarding their smoking habits [unexposed, SHS, or smokers]. Risk factors for positive IGRAs, LTBI, and active TB were defined. GM-CSF, IFN-γ, IL-2, IL-5, IL-10, IL-13, IL-22, IL-17, TNF-α, IL-1RA and IP-10 cytokines were detected in a subgroup of patients. Being SHS exposed was associated with a positive IGRA [aOR (95% CI): 8.7 (5.9-12.8)] and was a main factor related with LTBI [aOR (95% CI): 7.57 (4.79-11.94)] and active TB [aOR (95% CI): 3.40 (1.45-7.98)]. Moreover, IGRAs' sensitivity was reduced in active TB patients exposed to tobacco. IL-22, GM-CSF, IL-5, TNF-α, IP-10, and IL-13 were less secreted in LTBI children exposed to SHS. In conclusion, SHS is associated with LTBI and active TB in children. In addition, false-negative IGRAs obtained on active TB patients exposed to SHS, together with the decrease of specific cytokines released, suggest that tobacco may alter the immune response.
- Published
- 2022
- Full Text
- View/download PDF
5. Fujifilm SILVAMP TB-LAM for the Diagnosis of Tuberculosis in Nigerian Adults.
- Author
-
Comella-Del-Barrio P, Bimba JS, Adelakun R, Kontogianni K, Molina-Moya B, Osazuwa O, Creswell J, Cuevas LE, and Domínguez J
- Abstract
There is a need for diagnostics for tuberculosis (TB) that are easy to use, able to screen non-sputum samples, and able to provide rapid results for the management of both immunocompromised and immunocompetent individuals. The Fujifilm SILVAMP TB LAM (FujiLAM) assay, a new non-sputum based point of need test for the diagnosis of TB, could potentially address most of these needs. We evaluated the performance of FujiLAM in HIV positive and HIV negative patients with presumptive TB attending three district hospitals in Nigeria. Consecutive patients were asked to provide urine samples on the spot, which were tested with FujiLAM. The results were compared against a positive culture and/or Xpert MTB/RIF as the reference standard. Forty-five patients had bacteriologically confirmed TB, and 159 had negative culture and Xpert MTB/RIF (no TB). The FujiLAM test was positive in 23 (sensitivity 65.7%, 95% CI = 48-80) HIV negative and seven (70%, 95% CI = 35-92) HIV positive patients with bacteriological confirmation of TB. FujiLAM was negative in 97 (specificity 99.0%, 95% CI = 94-100) HIV negative and 56 (93.3%, 95% CI = 83-98) HIV positive patients without TB. The FujiLAM test has good diagnostic accuracy for considering its application in both HIV positive and HIV negative patients with TB.
- Published
- 2021
- Full Text
- View/download PDF
6. Perspectives for systems biology in the management of tuberculosis.
- Author
-
Kontsevaya I, Lange C, Comella-Del-Barrio P, Coarfa C, DiNardo AR, Gillespie SH, Hauptmann M, Leschczyk C, Mandalakas AM, Martinecz A, Merker M, Niemann S, Reimann M, Rzhepishevska O, Schaible UE, Scheu KM, Schurr E, Abel Zur Wiesch P, and Heyckendorf J
- Subjects
- Genomics, Humans, Metabolomics, Prospective Studies, Systems Biology, Tuberculosis diagnosis, Tuberculosis drug therapy
- Abstract
Standardised management of tuberculosis may soon be replaced by individualised, precision medicine-guided therapies informed with knowledge provided by the field of systems biology. Systems biology is a rapidly expanding field of computational and mathematical analysis and modelling of complex biological systems that can provide insights into mechanisms underlying tuberculosis, identify novel biomarkers, and help to optimise prevention, diagnosis and treatment of disease. These advances are critically important in the context of the evolving epidemic of drug-resistant tuberculosis. Here, we review the available evidence on the role of systems biology approaches - human and mycobacterial genomics and transcriptomics, proteomics, lipidomics/metabolomics, immunophenotyping, systems pharmacology and gut microbiomes - in the management of tuberculosis including prediction of risk for disease progression, severity of mycobacterial virulence and drug resistance, adverse events, comorbidities, response to therapy and treatment outcomes. Application of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach demonstrated that at present most of the studies provide "very low" certainty of evidence for answering clinically relevant questions. Further studies in large prospective cohorts of patients, including randomised clinical trials, are necessary to assess the applicability of the findings in tuberculosis prevention and more efficient clinical management of patients., Competing Interests: Conflict of Interest: I. Kontsevaya has nothing to disclose. Conflict of interest: C. Lange reports personal fees from Chiesi, Gilead, Janssen, Lucane, Novartis, Oxoid, Berlin Chemie, Thermofisher and Oxfordimmunotec, outside the submitted work. Conflict of interest: P. Comella-del-Barrio has nothing to disclose. Conflict of interest: C. Coarfa has nothing to disclose. Conflict of interest: A.R. DiNardo has nothing to disclose. Conflict of interest: S.H. Gillespie reports non-financial support from LifeArc, during the conduct of the study; and other support from ODx Innovations, outside the submitted work. Conflict of interest: M. Hauptmann has nothing to disclose. Conflict of interest: C. Leschczyk has nothing to disclose. Conflict of interest: A.M. Mandalakas has nothing to disclose. Conflict of interest: A. Martinecz has nothing to disclose. Conflict of interest: M. Merker has nothing to disclose. Conflict of interest: S. Niemann reports grants from German Center for Infection Research, Excellenz Cluster Precision Medicine in Chronic Inflammation EXC 2167, and Leibniz Science Campus Evolutionary Medicine of the LUNG (EvoLUNG), during the conduct of the study. Conflict of interest: M. Reimann has nothing to disclose. Conflict of interest: O. Rzhepishevska has nothing to disclose. Conflict of interest: U.E. Schaible has nothing to disclose. Conflict of interest: K.M. Scheu has nothing to disclose. Conflict of interest: E. Schurr has nothing to disclose. Conflict of interest: P. Abel zur Wiesch has nothing to disclose. Conflict of interest: J. Heyckendorf has nothing to disclose., (Copyright ©The authors 2021.)
- Published
- 2021
- Full Text
- View/download PDF
7. Diagnostic Performance of the Fujifilm SILVAMP TB-LAM in Children with Presumptive Tuberculosis.
- Author
-
Comella-Del-Barrio P, Molina-Moya B, Gautier J, Villar-Hernández R, Doresca MJC, Sallés-Mingels B, Canales-Aliaga L, Narcisse M, Pérez-Porcuna TM, Creswell J, Cuevas LE, and Domínguez J
- Abstract
Current diagnostics for tuberculosis (TB) only manage to confirm a small proportion of children with TB and require respiratory samples, which are difficult to obtain. There is a need for non-invasive biomarker-based tests as an alternative to sputum testing. Fujifilm SILVAMP TB lipoarabinomannan (FujiLAM), a lateral-flow test to detect lipoarabinomannan in urine, is a novel non-sputum-based point-of-care diagnostic reported to have increased sensitivity for the diagnosis of TB among human immunodeficiency virus (HIV)-infected adults. We evaluate the performance of FujiLAM in children with presumptive TB. Fifty-nine children attending a paediatric hospital in Haiti with compatible signs and symptoms of TB were examined using Xpert MTB/RIF, smear microscopy and X-rays, and classified according to the certainty of diagnosis into bacteriologically confirmed TB ( n = 5), unconfirmed TB (bacteriologically negative, n = 50) and unlikely TB ( n = 4). Healthy children ( n = 20) were enrolled as controls. FujiLAM sensitivity and specificity were 60% and 95% among children with confirmed TB. FujiLAM's high specificity and its characteristics as a point-of-care indicate the test has a good potential for the diagnosis of TB in children.
- Published
- 2021
- Full Text
- View/download PDF
8. Impact of COVID-19 on Tuberculosis Control.
- Author
-
Comella-Del-Barrio P, De Souza-Galvão ML, Prat-Aymerich C, and Domínguez J
- Published
- 2021
- Full Text
- View/download PDF
9. A Model Based on the Combination of IFN-γ, IP-10, Ferritin and 25-Hydroxyvitamin D for Discriminating Latent From Active Tuberculosis in Children.
- Author
-
Comella-Del-Barrio P, Abellana R, Villar-Hernández R, Jean Coute MD, Sallés Mingels B, Canales Aliaga L, Narcisse M, Gautier J, Ascaso C, Latorre I, Dominguez J, and Perez-Porcuna TM
- Abstract
In recent years, pediatric research on tuberculosis (TB) has focused on addressing new biomarkers with the potential to be used as immunological non-sputum-based methods for the diagnosis of TB in children. The aim of this study was to characterize a set of cytokines and a series of individual factors (ferritin, 25-hydroxyvitamin D [25(OH)D], parasite infections, and nutritional status) to assess different patterns for discriminating between active TB and latent TB infection (LTBI) in children. The levels of 13 cytokines in QuantiFERON-TB Gold In-Tube (QFT-GIT) supernatants were analyzed in 166 children: 74 with active TB, 37 with LTBI, and 55 uninfected controls. All cytokines were quantified using Luminex or ELISA. Ferritin and 25(OH)D were also evaluated using CLIA, and Toxocara canis Ig-G antibodies were detected with a commercial ELISA kit. The combination of IP-10, IFN-γ, ferritin, and 25(OH)D achieved the best diagnostic performance to discriminate between active TB and LTBI cases in children in relation to the area under receiver operating characteristic (ROC) curve 0.955 (confidence interval 95%: 0.91-1.00), achieving optimal sensitivity and specificity for the development of a new test (93.2 and 90.0%, respectively). Children with TB showed higher ferritin levels and an inverse correlation between 25(OH)D and IFN-γ levels. The model proposed includes a combination of biomarkers for discriminating between active TB and LTBI in children to improve the accuracy of TB diagnosis in children. This combination of biomarkers might have potential for identifying the onset of primary TB in children.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.